Matches in Nanopublications for { ?s ?p "[In the present study, we investigated whether the hypolipidemic drug bezafibrate, which is a pan-agonist of all PPAR-isoforms, might induce FALDH activity in human fibroblasts of control subjects and SLS patients that still have some residual FALDH activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion description "[In the present study, we investigated whether the hypolipidemic drug bezafibrate, which is a pan-agonist of all PPAR-isoforms, might induce FALDH activity in human fibroblasts of control subjects and SLS patients that still have some residual FALDH activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.